Interleukin‐6 as a Potential Biomarker for Alzheimer’s Disease: A Meta‐Analysis with Moderator Effects
These findings support IL-6 as a potential peripheral biomarker for both diagnosis and disease severity assessment in AD. However, standardized protocols and larger prospective studies are essential to validate its clinical applicability and improve reproducibility.
Authors
- Kahye Kim
- Jaeuk U. Kim (ORCID: https://orcid.org/0000-0003-0408-5569)
- Ji‐Woo Suk
- Jin Mi Chun
Institutions
- Korea Institute of Oriental Medicine (KR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70861_108694
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00